Current Pharmaceutical Design
Title: Preface
Volume: 7 Issue: 16
Author(s): Elke S. Bergmann-Leitner
Affiliation:
Export Options
About this article
Cite this article as:
Elke S. Bergmann-Leitner , Preface, Current Pharmaceutical Design 2001; 7 (16) . https://dx.doi.org/10.2174/1381612013397195
DOI https://dx.doi.org/10.2174/1381612013397195 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
13
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Emerging Role of Stereotactic Radiotherapy (SRT) in the Treatment of Early Stage Non-Small Cell Lung Cancer
Current Cancer Therapy Reviews Armed Oncolytic Adenoviruses and Polymer-shielded Nanocomplex for Systemic Delivery
Current Cancer Therapy Reviews Molecule of the Month
Current Topics in Medicinal Chemistry Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress
Current Drug Metabolism Molecular Docking for Identification of Potential Targets for Drug Repurposing
Current Topics in Medicinal Chemistry Cetuximab Immunoliposomes Enhance Delivery of 5-FU to Skin Squamous Carcinoma Cells
Anti-Cancer Agents in Medicinal Chemistry Peptidomimetic Design of CDK Inhibitors Targeting theRecruitment Site of the Cyclin Subunit
Current Medicinal Chemistry - Anti-Cancer Agents Antibodies for Therapeutic Uses and the Evolution of Biotechniques
Current Medicinal Chemistry Editorial [Hot Topic: Emerging Therapeutic Targets and Agents for Glioblastoma Therapy – Part I (Guest Editor: Hui-Wen Lo)]
Anti-Cancer Agents in Medicinal Chemistry Viral Vectors in Cancer Immunotherapy: Which Vector for Which Strategy?
Current Gene Therapy Autologous Adipose-Derived Regenerative Cells for Therapeutic Angiogenesis
Current Pharmaceutical Design Proteomic Validation of Protease Drug Targets: Pharmacoproteomics of Matrix Metalloproteinase Inhibitor Drugs Using Isotope-Coded Affinity Tag Labelling and Tandem Mass Spectrometry
Current Pharmaceutical Design Lipid Nucleoside Conjugates for the Treatment of Cancer
Current Pharmaceutical Design Update on Screening in Prostate Cancer Based on Recent Clinical Trials
Reviews on Recent Clinical Trials Membrane Targeted Anticancer Drugs: Potent Inducers of Apoptosis and Putative Radiosensitisers
Current Medicinal Chemistry - Anti-Cancer Agents Self-assembled Nucleic Acid Nanostructures for Cancer Theranostic Medicines
Current Topics in Medicinal Chemistry ABC Transporters and Drug Resistance in Patients with Epilepsy
Current Pharmaceutical Design Wnt Signaling and Prostate Cancer
Current Drug Targets Celecoxib in Cancer Therapy and Prevention – Review
Current Drug Targets Advances and Application of DNA-functionalized Nanoparticles
Current Medicinal Chemistry